UB Paderborn / Katalog / Suche / in CDI

1 – 22 von 22

Sortiert nach

CXCR2 Antagonist MK-7123. A Phase 2 Proof-of-Concept Trial for Chronic Obstructive Pulmonary Disease

American journal of respiratory and critical care medicine, 2015-05, Vol.191 (9), p.1001-1011

2015

Volltextzugriff (PDF)

Challenge of multiple co-primary endpoints: a new approach

Statistics in medicine, 2007-03, Vol.26 (6), p.1181-1192

2007

Volltextzugriff (PDF)

Onset of symptomatic effect of mometasone furoate nasal spray in the treatment of nasal polyposis

Journal of allergy and clinical immunology, 2008-04, Vol.121 (4), p.928-932

2008

Volltextzugriff (PDF)

One-year treatment with mometasone furoate in chronic obstructive pulmonary disease

Respiratory research, 2008-11, Vol.9 (1), p.73-73, Article 73

2008

Volltextzugriff (PDF)

Effectiveness of Elbasvir and Grazoprevir Combination, With or Without Ribavirin, for Treatment-Experienced Patients With Chronic Hepatitis C Infection

Gastroenterology (New York, N.Y. 1943), 2017-01, Vol.152 (1), p.164-175.e4

2017

Volltextzugriff (PDF)

Multiple Co-primary Endpoints: Medical and Statistical Solutions: A Report from the Multiple Endpoints Expert Team of the Pharmaceutical Research and Manufacturers of America

Therapeutic innovation & regulatory science, 2007-01, Vol.41 (1), p.31-46

2007

Volltextzugriff (PDF)

Efficacy and safety of mometasone furoate nasal spray in nasal polyposis

Journal of allergy and clinical immunology, 2005-12, Vol.116 (6), p.1275-1281

2005

Volltextzugriff (PDF)

Evaluation of two doses of etoricoxib, a COX-2 selective non-steroidal anti-inflammatory drug (NSAID), in the treatment of Rheumatoid Arthritis in a double-blind, randomized controlled trial

BMC musculoskeletal disorders, 2016-08, Vol.17 (1), p.331-331, Article 331

2016

Volltextzugriff (PDF)

Five-year Safety Data From OPUS, a European Observational Safety Registry for Adults With Ulcerative Colitis Treated With Originator Infliximab [Remicade®] or Conventional Therapy

Journal of Crohn's and colitis, 2019-09, Vol.13 (9), p.1148-1157

2019

Volltextzugriff (PDF)

Safety of mometasone furoate nasal spray in the treatment of nasal polyps in children

Pediatric allergy and immunology, 2013-02, Vol.24 (1), p.33-38

2013

Volltextzugriff (PDF)

Effects of Inhaled Mometasone Furoate on Growth Velocity and Adrenal Function: A Placebo-Controlled Trial in Children 4-9 Years Old with Mild Persistent Asthma

The Journal of asthma, 2011-10, Vol.48 (8), p.848-859

2011

Volltextzugriff (PDF)

Humoral immunity and delayed-type hypersensitivity in healthy subjects treated for 30 days with MK-7123, a selective CXCR2 antagonist

International immunopharmacology, 2013-10, Vol.17 (2), p.178-183

2013

Volltextzugriff (PDF)

901f Efficacy and Safety of Grazoprevir/Elbasvir ± Ribavirin (RBV) for 12 or 16 Weeks in Patients With HCV G1, G4, or G6 Infection Who Previously Failed Peginterferon/RBV: C-EDGE Treatment-Experienced Trial

Gastroenterology (New York, N.Y. 1943), 2015-04, Vol.148 (4), p.S-1194-S-1195

2015

Volltextzugriff (PDF)

Humoral immunity and delayed-type hypersensitivity in healthy subjects treated for 30days with MK-7123, a selective CXCR2 antagonist

International immunopharmacology, 2013-10, Vol.17 (2), p.178-183

2013

Volltextzugriff (PDF)

Comparative Effects of Desloratadine versus Montelukast on Asthma Symptoms and Use of β2-Agonists in Patients with Seasonal Allergic Rhinitis and Asthma

International archives of allergy and immunology, 2003, Vol.130 (4), p.307-313

2003

Volltextzugriff (PDF)

RAPID ONSET OF SIGNIFICANT IMPROVEMENTS IN PEAK EXPIRATORY FLOW AMONG CHILDREN WITH ASTHMA TREATED WITH MOMETASONE FUROATE ADMINISTERED VIA A DRY POWDER INHALER

Chest, 2008-10, Vol.134 (4), p.51

2008

Volltextzugriff (PDF)

MOMETASONE FUROATE ADMINISTERED VIA A DRY POWDER INHALER REDUCES THE SEVERITY OF AIRFLOW OBSTRUCTION IN CHILDREN WITH ASTHMA: FINDINGS FROM ANALYSIS OF FEV1/FVC RATIOS

Chest, 2008-10, Vol.134 (4), p.52

2008

Volltextzugriff (PDF)

Dose-dependent Effects of Inhaled Mometasone Furoate on Airway Function and Inflammation After Allergen Inhalation Challenge

American journal of respiratory and critical care medicine, 2001-08, Vol.164 (4), p.569-574

2001

Volltextzugriff (PDF)

Mometasone furoate antagonizes AMP-induced bronchoconstriction in patients with mild asthma

Journal of allergy and clinical immunology, 2000-05, Vol.105 (5), p.906-911

2000

Volltextzugriff (PDF)

Comparative Effects of Desloratadine versus Montelukast on Asthma Symptoms and Use of [beta]2-Agonists in Patients with Seasonal Allergic Rhinitis and Asthma

International archives of allergy and immunology, 2003-04, Vol.130 (4), p.307

2003

Volltextzugriff (PDF)

Comparative effects of desloratadine versus montelukast on asthma symptoms and use of beta 2-agonists in patients with seasonal allergic rhinitis and asthma

International archives of allergy and immunology, 2003-04, Vol.130 (4), p.307-313

2003

Volltextzugriff (PDF)

Safety and efficacy of a CXCR2 antagonist in patients with severe asthma and sputum neutrophils: a randomized, placebo-controlled clinical trial

Clinical and experimental allergy, 2012-07, Vol.42 (7), p.1097-1103

2012

Volltextzugriff (PDF)

1 – 22 von 22

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(22)
Mit Volltextzugriff
(22)

Publikationsform

Artikel
(22)

Sprache

Englisch
(22)
Japanisch
(5)
Welsh
(1)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(15)
Science & Technology
(15)
Humans
(14)
Female
(13)
Male
(13)
Adult
(10)
Double-Blind Method
(10)
Aged
(9)
Middle Aged
(9)
Adolescent
(7)
Biological And Medical Sciences
(7)
Mometasone Furoate
(7)
Pregnadienediols - Administration & Dosage
(7)
Allergy
(6)
Immunology
(6)
Medical Sciences
(6)
Anti-Inflammatory Agents - Administration & Dosage
(5)
Asthma - Drug Therapy
(5)
Respiratory System
(5)
Asthma
(4)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

CXCR2 Antagonist MK-7123. A Phase 2 Proof-of-Concept Trial for Chronic Obstructive Pulmonary Disease

Challenge of multiple co-primary endpoints: a new approach

Onset of symptomatic effect of mometasone furoate nasal spray in the treatment of nasal polyposis

One-year treatment with mometasone furoate in chronic obstructive pulmonary disease

Effectiveness of Elbasvir and Grazoprevir Combination, With or Without Ribavirin, for Treatment-Experienced Patients With Chronic Hepatitis C Infection

Multiple Co-primary Endpoints: Medical and Statistical Solutions: A Report from the Multiple Endpoints Expert Team of the Pharmaceutical Research and Manufacturers of America

Efficacy and safety of mometasone furoate nasal spray in nasal polyposis

Evaluation of two doses of etoricoxib, a COX-2 selective non-steroidal anti-inflammatory drug (NSAID), in the treatment of Rheumatoid Arthritis in a double-blind, randomized controlled trial

Five-year Safety Data From OPUS, a European Observational Safety Registry for Adults With Ulcerative Colitis Treated With Originator Infliximab [Remicade®] or Conventional Therapy

Safety of mometasone furoate nasal spray in the treatment of nasal polyps in children

Effects of Inhaled Mometasone Furoate on Growth Velocity and Adrenal Function: A Placebo-Controlled Trial in Children 4-9 Years Old with Mild Persistent Asthma

Humoral immunity and delayed-type hypersensitivity in healthy subjects treated for 30 days with MK-7123, a selective CXCR2 antagonist

901f Efficacy and Safety of Grazoprevir/Elbasvir ± Ribavirin (RBV) for 12 or 16 Weeks in Patients With HCV G1, G4, or G6 Infection Who Previously Failed Peginterferon/RBV: C-EDGE Treatment-Experienced Trial

Humoral immunity and delayed-type hypersensitivity in healthy subjects treated for 30days with MK-7123, a selective CXCR2 antagonist

Comparative Effects of Desloratadine versus Montelukast on Asthma Symptoms and Use of β2-Agonists in Patients with Seasonal Allergic Rhinitis and Asthma

RAPID ONSET OF SIGNIFICANT IMPROVEMENTS IN PEAK EXPIRATORY FLOW AMONG CHILDREN WITH ASTHMA TREATED WITH MOMETASONE FUROATE ADMINISTERED VIA A DRY POWDER INHALER

MOMETASONE FUROATE ADMINISTERED VIA A DRY POWDER INHALER REDUCES THE SEVERITY OF AIRFLOW OBSTRUCTION IN CHILDREN WITH ASTHMA: FINDINGS FROM ANALYSIS OF FEV1/FVC RATIOS

Dose-dependent Effects of Inhaled Mometasone Furoate on Airway Function and Inflammation After Allergen Inhalation Challenge

Mometasone furoate antagonizes AMP-induced bronchoconstriction in patients with mild asthma

Comparative Effects of Desloratadine versus Montelukast on Asthma Symptoms and Use of [beta]2-Agonists in Patients with Seasonal Allergic Rhinitis and Asthma

Comparative effects of desloratadine versus montelukast on asthma symptoms and use of beta 2-agonists in patients with seasonal allergic rhinitis and asthma

Safety and efficacy of a CXCR2 antagonist in patients with severe asthma and sputum neutrophils: a randomized, placebo-controlled clinical trial

Suchergebnisse filtern